Research Phase
One of the most potent growth-hormone-releasing peptides studied, with a distinct cardioprotective effect separate from its GH-stimulating activity.
Cardiovascular Support
FDA Approved
The FDA-approved GLP-1 behind Ozempic and Wegovy. Reduces appetite, blood sugar, and heart disease risk.
Clinical Trials
A breakthrough peptide that recharges aging or damaged mitochondria. Just approved by the FDA for a rare muscle disease.
FDA Approved
An FDA-approved weekly injection for diabetes and weight loss. Delivers the strongest results of any approved weight-loss medication to date.